| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 48 |
| 1 | METFORMIN | 21 |
| 2 | METFORMIN ER 500 MG | 21 |
| 3 | METFORMIN ER 750 MG | 21 |
| 4 | INSULIN LISPRO | 10 |
| 5 | CANAGLIFLOZIN | 9 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE | 9 |
| 7 | INSULIN | 9 |
| 8 | INSULIN GLARGINE | 8 |
| 9 | ACETAMINOPHEN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0014 |
| 1 | TAURINE | 1 | 0.0013 |
| 2 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 4 | 0.0011 |
| 3 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 4 | EMPAGLIFLOZIN | 48 | 0.0007 |
| 5 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| 6 | DIMENHYDRINATE | 5 | 0.0005 |
| 7 | BACLOFEN INJECTION | 1 | 0.0003 |
| 8 | ALEMTUZUMAB | 6 | 0.0003 |
| 9 | CANAGLIFLOZIN | 9 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 55 | 0.0005 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 5 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 8 | Sympathomimetic-like Agent [EPC] | 3 | 0.0001 |
| 9 | Insulin Analog [EPC] | 28 | 0.0001 |